A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation (AF)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation (AF)

Bibliographic Details
Main Authors:	Kim, Y, Zhang, Y, Guzik, T, Kattach, H, Pillai, R, Ratnatunga, C, Channon, K, Casadei, B
Format:	Conference item
Published:	2003

Similar Items

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.
by: Kim, Y, et al.
Published: (2005)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
by: Kim, Y, et al.
Published: (2005)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
by: Kim, Y, et al.
Published: (2005)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after coronary artery bypass graft surgery
by: Kim, Y, et al.
Published: (2006)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after on-pump coronary artery bypass graft surgery
by: Kim, Y, et al.
Published: (2005)

Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery.
by: Kim, Y, et al.
Published: (2008)

Superoxide generation during cardiopulmonary bypass in conventional coronary artery bypass graft surgery: is there a role for myocardial NAD(P)H oxidase?
by: Kim, Y, et al.
Published: (2004)

Superoxide generation by NAD(P)H oxidase in human sphenous vein: Interaction with nitric oxide
by: Guzik, T, et al.
Published: (2000)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.
by: Guzik, T, et al.
Published: (2004)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins
by: Guzik, T, et al.
Published: (2004)

Systemic upregulation of vascular NAD(P)H oxidase in human atherosclerosis: Association with clinical risk factors.
by: Guzik, T, et al.
Published: (2000)

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.
by: Guzik, T, et al.
Published: (2000)

Superoxide production by NAD(P)H oxidase in human blood vessels: Functional interaction with nitric oxide
by: Guzik, T, et al.
Published: (2000)

154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
by: Mighiu, A, et al.
Published: (2017)

Relationship of NAD(P)H oxidase activity in human blood vessels to endothelial dysfunction and clinical risk factors
by: Guzik, T, et al.
Published: (2000)

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.
by: Guzik, T, et al.
Published: (2002)

UltraRapid communications : vascular superoxide production by NAD(P)H OxidaseAssociation with endothelial dysfunction and clinical risk factors
by: Guzik, T, et al.
Published: (2000)

Functional impact of genetic polymorphisms in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis
by: Guzik, T, et al.
Published: (2000)

Association of superoxide production by NAD(P)H oxidase with systaemic endothelial dysfunction in human blood vessels: relationship to clinical risk factors
by: Guzik, T, et al.
Published: (2000)

Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis.
by: Guzik, T, et al.
Published: (2000)

Functional importance of C242T polymorphism in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis
by: Guzik, T, et al.
Published: (2000)

Relationships of promoter and coding sequence genetic polymorphisms of p22phox subunit to the vascular NAD(P)H oxidase activity
by: Guzik, T, et al.
Published: (2004)

Vascular superoxide generation by NAD(P)H oxidase is increased in humans with type II diabetes mellitus
by: Guzik, T, et al.
Published: (2001)

Molecular mechanisms underlying the myocardial nitric oxide-redox imbalance in human atrial fibrillation
by: Reilly, SN, et al.
Published: (2009)

Superoxide generation by NAD(P)H oxidases in human bypass graft vessels.
by: Guzik, T, et al.
Published: (2002)

Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
by: Mighiu, AS, et al.
Published: (2021)

Vascular superoxide production in human coronary artery disease. Relationships between Nox expression and oxidase activity
by: Guzik, T, et al.
Published: (2004)

Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
by: West, N, et al.
Published: (2001)

Increased NAD(P)H oxidase activity in coronary arteries from patients with coronary artery disease
by: Guzik, T, et al.
Published: (2001)

Modulation of atrial fibrillation susceptibility by gp91phox-containing NADPH oxidases
by: Mighiu, A
Published: (2018)

Mechanisms regulating myocardial redox state in chronic atrial fibrillation: the role of NADPH-oxidase and uncoupled nitric oxide synthases
by: Margaritis, M, et al.
Published: (2010)

Enhanced superoxide anion production in experimental venous bypass grafts is mediated by NAD(P)H oxidase
by: West, N, et al.
Published: (2000)

Atrial Fibrillation Causes a Progressive, Time-Dependent Reduction in Myocardial Neuronal NOS in Humans and Goats: Implications for AF-Induced Electrical Remodeling
by: Reilly, S, et al.
Published: (2012)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
by: Reilly, S, et al.
Published: (2009)

Myocardial Redox State Predicts Post-Operative Atrial Fibrillation in Cardiac Surgery
by: Demosthenous, M, et al.
Published: (2011)

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial
by: Eduard Shantsila, et al.
Published: (2020-09-01)

Myocardial superoxide and peroxynitrite as strong independent predictors of paroxysmal atrial fibrillation post-CABG
by: Demosthenous, M, et al.
Published: (2011)

“The obesity paradox” in patients with atrial fibrillation according to the results of the REKUR-AF study
by: Inna L. Polshakova, et al.
Published: (2021-12-01)

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study
by: Cecilia Politi, et al.
Published: (2016-02-01)

NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation
by: Roberto Ramos-Mondragón, et al.
Published: (2023-10-01)